| Changes in rosacea comorbidities and treatment utilization over time. | |
| | |
MedLine Citation:
|
PMID: 21061763 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
BACKGROUND: Rosacea is a chronic skin condition that requires lifelong treatment. Given the rise in antibiotic-resistant bacteria, many physicians are re-evaluating their use of antibiotics for long-term treatment of rosacea. PURPOSE: To examine trends in the treatment of rosacea and the comorbidities associated with this skin condition. METHODS: From 2002-2006, the National Ambulatory Medical Care Survey queried drug mentions at rosacea visits and coexisting diagnoses. Prescribing patterns of dermatologists were compared to other physicians' patterns. RESULTS: Ten million physician visits had the diagnosis of rosacea; 74 percent were associated with co-morbidities. Metronidazole, tetracyclines, azelaic acid and sodium sulfacetamide were the top medications mentioned at rosacea visits. Prescriptions increased for azelaic acid and decreased for sodium sulfacetamide. Dermatologists decreased their prescribing of systemic medications. CONCLUSION: Dermatologists are reducing their use of systemic antibiotics for rosacea and turning to therapies, such as azelaic acid, that do not have potential to induce bacterial resistance. |
| | |
Authors:
|
Brad A Yentzer; Alan B Fleischer |
Related Documents
:
|
18551883 - The epidemiologic association between opioid prescribing, non-medical use, and emergenc... 879183 - Neonatal medication surveillance by the pharmacist. 18390103 - Obstructive urolithiasis, unilateral hydronephrosis, and probable nephrolithiasis in a ... |
Publication Detail:
|
Type: Journal Article; Research Support, Non-U.S. Gov't |
Journal Detail:
|
Title: Journal of drugs in dermatology : JDD Volume: 9 ISSN: 1545-9616 ISO Abbreviation: J Drugs Dermatol Publication Date: 2010 Nov |
Date Detail:
|
Created Date: 2010-11-10 Completed Date: 2010-12-15 Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 101160020 Medline TA: J Drugs Dermatol Country: United States |
Other Details:
|
Languages: eng Pagination: 1402-6 Citation Subset: IM |
Affiliation:
|
Department of Dermatology, Wake Forest University School of Medicine, Winston-Salem, NC 27157-1071, USA. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Anti-Bacterial Agents
/
administration & dosage Dermatologic Agents / therapeutic use Drug Utilization / statistics & numerical data Female Humans Male Physician's Practice Patterns* Rosacea / complications, drug therapy* Skin Diseases / complications |
| Chemical | |
Reg. No./Substance:
|
0/Anti-Bacterial Agents; 0/Dermatologic Agents |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Treatment of 2,453 acne vulgaris patients aged 12-17 years with the fixed-dose adapalene-benzoyl per...
Next Document: Doxycycline and minocycline for the management of acne: a review of efficacy and safety with emphasi...